DE69133277D1 - Chelat-zubereitungen, die oximverbindungen enthalten - Google Patents

Chelat-zubereitungen, die oximverbindungen enthalten

Info

Publication number
DE69133277D1
DE69133277D1 DE69133277T DE69133277T DE69133277D1 DE 69133277 D1 DE69133277 D1 DE 69133277D1 DE 69133277 T DE69133277 T DE 69133277T DE 69133277 T DE69133277 T DE 69133277T DE 69133277 D1 DE69133277 D1 DE 69133277D1
Authority
DE
Germany
Prior art keywords
group
alkyl
heteroaryl
aryl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69133277T
Other languages
English (en)
Other versions
DE69133277T2 (de
Inventor
Dean Bush
Lynn Bissett
Ranjit Chatterjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE69133277D1 publication Critical patent/DE69133277D1/de
Application granted granted Critical
Publication of DE69133277T2 publication Critical patent/DE69133277T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
DE69133277T 1990-04-26 1991-04-09 Chelat-zubereitungen, die oximverbindungen enthalten Expired - Fee Related DE69133277T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US51499890A 1990-04-26 1990-04-26
US514998 1990-04-26
US65784791A 1991-02-25 1991-02-25
US657847 1991-02-25
PCT/US1991/002398 WO1991016034A1 (en) 1990-04-26 1991-04-09 Chelator compositions comprising oxime compounds

Publications (2)

Publication Number Publication Date
DE69133277D1 true DE69133277D1 (de) 2003-07-17
DE69133277T2 DE69133277T2 (de) 2004-04-08

Family

ID=27058372

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69133277T Expired - Fee Related DE69133277T2 (de) 1990-04-26 1991-04-09 Chelat-zubereitungen, die oximverbindungen enthalten

Country Status (8)

Country Link
US (1) US5364617A (de)
EP (1) EP0611301B1 (de)
AT (1) ATE242625T1 (de)
AU (1) AU662101B2 (de)
CA (1) CA2079485C (de)
DE (1) DE69133277T2 (de)
ES (1) ES2199214T3 (de)
WO (1) WO1991016034A1 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439954A (en) * 1991-10-11 1995-08-08 The Procter & Gamble Company Substituted phenyl-1,3-diketones as protectants against skin damage
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
WO1995001157A1 (en) * 1993-06-29 1995-01-12 The Procter & Gamble Company Use of hydroxyphenyl oximes as chelating photoprotectants
WO1995027485A1 (en) * 1994-04-08 1995-10-19 The Procter & Gamble Company Methods of using iron chelating compounds to reduce free radical damage in mammals
US5922758A (en) * 1994-09-21 1999-07-13 The Procter & Gamble Company Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage
US5739156A (en) * 1994-09-21 1998-04-14 The Procter & Gamble Company Methods of using 2,4-dienoic acid esters of tocopherols to reduce free radical damage in mammalian cells
US5624664A (en) * 1995-01-30 1997-04-29 Lambrechts; John Skin conditioning composition and softgel filled therewith
WO1996040042A2 (en) * 1995-06-07 1996-12-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Stabilized steroid compositions
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US5829449A (en) * 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
JP2003528031A (ja) * 1999-08-24 2003-09-24 ザ、プロクター、エンド、ギャンブル、カンパニー オキシム化合物含有組成物の局所適用によるケラチン組織のライトニング方法
DE10031703A1 (de) * 2000-06-29 2002-01-10 Beiersdorf Ag Verwendung von Calcium freisetzenden oder bindenden Substanzen zur gezielten Schächung oder Stärkung der Barrierefunktion der Haut
AU2002220121A1 (en) * 2000-11-28 2002-06-11 Lorillard Licensing Company, Llc A smoking article including a selective carbon monoxide pump
US6481442B1 (en) 2000-11-28 2002-11-19 Lorillard Licensing Company, Llc Smoking article including a filter for selectively removing carbonyls
US6677294B2 (en) 2000-11-29 2004-01-13 The Procter & Gamble Company Cleansing compositions
ITPI20010014A1 (it) * 2001-03-05 2002-09-05 Ivo Pera Composto per filtri per sigarette,o altri articoli da fumo,a base di sostanze antiossidanti ed il filtro cosi'ottenuto
US20020182237A1 (en) 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
US20050281766A1 (en) * 2002-03-11 2005-12-22 Avon Products, Inc. Method of improving the aesthetic appearance of epithelia
US7235249B2 (en) 2002-03-28 2007-06-26 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
US7098189B2 (en) 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
EP1572147A1 (de) 2002-12-20 2005-09-14 The Procter & Gamble Company Textilartige körperpflegeartikel
US20040175347A1 (en) 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
US20050003024A1 (en) 2003-03-04 2005-01-06 The Procter & Gamble Company Regulation of mammalian hair growth
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
KR101045658B1 (ko) 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물
US20070191368A1 (en) * 2004-03-23 2007-08-16 Bissett Donald L Inhibition of tissue damage to skin from radiation treatment therapy
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US8147853B2 (en) 2005-02-15 2012-04-03 The Procter & Gamble Company Personal care compositions containing hydrophobically modified non-platelet particles
FR2890310B1 (fr) 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
US7614812B2 (en) 2005-09-29 2009-11-10 Kimberly-Clark Worldwide, Inc. Wiper with encapsulated agent
US7485609B2 (en) * 2005-09-29 2009-02-03 Kimberly-Clark Worldwide, Inc. Encapsulated liquid cleanser
WO2007041627A1 (en) 2005-10-03 2007-04-12 Pinsky Mark A Compositions and methods for improved skin care
FR2900573B1 (fr) 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
CN100475189C (zh) 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
CN104473966A (zh) 2007-09-28 2015-04-01 强生消费者公司 产生电流的颗粒及其用途
US20090187060A1 (en) * 2008-01-22 2009-07-23 E-Z-Em, Inc. Method and Formulation for Neutralizing Toxic Chemicals and Materials
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
WO2010082177A2 (en) 2009-01-16 2010-07-22 Sederma New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
WO2011018472A2 (en) 2009-08-14 2011-02-17 Basf Se Methods in cell cultures, and related inventions, employing certain additives
WO2011042423A2 (en) 2009-10-06 2011-04-14 Basf Se Stabilization of household, body-care and food products by using benzotropolone containing plant extracts and/or related benzotropolone derivatives
US20110166370A1 (en) 2010-01-12 2011-07-07 Charles Winston Saunders Scattered Branched-Chain Fatty Acids And Biological Production Thereof
CA2800537C (en) 2010-06-11 2016-02-09 The Procter & Gamble Company Compositions for treating skin
US20120172281A1 (en) 2010-07-15 2012-07-05 Jeffrey John Scheibel Detergent compositions comprising microbially produced fatty alcohols and derivatives thereof
CA2803380A1 (en) 2010-07-15 2012-01-19 The Procter & Gamble Company A personal care composition comprising a near-terminal branched compound
CN103025335A (zh) 2010-07-23 2013-04-03 强生消费者公司 产生腐蚀电流的金属颗粒及其用途
DE102010045890A1 (de) * 2010-09-17 2012-03-22 Merck Patent Gmbh 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung
WO2013091894A2 (en) 2011-12-21 2013-06-27 Flavin Dana Topical compositions
US8895041B2 (en) 2012-03-23 2014-11-25 The Procter & Gamble Company Compositions for delivering perfume to the skin
BR112015021683A2 (pt) 2013-03-05 2017-07-18 Procter & Gamble composições de açúcar misturadas
EP2857004B1 (de) 2013-10-07 2018-07-04 The Procter and Gamble Company Haarglättungsverfahren mit reduzierenden Zuckern
CN106715463B (zh) 2013-12-10 2020-10-16 苏塞克斯研究实验室 糖化肽组合物及其用途
MX2016007779A (es) 2013-12-19 2016-09-07 Procter & Gamble Formacion de fibras de queratina mediante el uso de ester de carbonato.
CN105828793B (zh) 2013-12-19 2019-06-18 宝洁公司 使用糖使角蛋白纤维成形
MX361097B (es) 2013-12-19 2018-11-27 Procter & Gamble Formación de fibras de queratina mediante el uso de una amina o diamina.
MX361102B (es) 2013-12-19 2018-11-27 Procter & Gamble Modelado de fibras de queratina con el uso de un agente activo que comprende al menos dos grupos funcionales seleccionados de: -c(oh)- y -c(=o)oh.
WO2015095685A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using 2-hydroxypropane-1,2,3-tricarboxylic acid and/or 1,2,3,4-butanetetracarboxylic acid
WO2015094837A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using carbonate ester
EP3082733A1 (de) 2013-12-19 2016-10-26 The Procter & Gamble Company Formgebung von keratinfasern mit einem wirkstoff mit einer aus einer aus -c(= o) -, -c (= o) -h, -c und (= o) -o-bestehenden gruppe ausgewählten funktionellen gruppe
WO2015095671A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using oxoethanoic acid and/or derivatives thereof
US20150352034A1 (en) 2014-06-08 2015-12-10 Solazyme, Inc. Personal Care Products Containing Microalgae or Extracts Thereof
US20160000682A1 (en) 2014-07-02 2016-01-07 Geoffrey Brooks Consultants Llc Peptide-Based Compositions and Methods of Use
CN107148263B (zh) 2014-11-10 2021-07-06 宝洁公司 个人护理组合物
MX2017006149A (es) 2014-11-10 2017-07-27 Procter & Gamble Composiciones para el cuidado personal con dos fases beneficas.
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
WO2016077325A1 (en) 2014-11-10 2016-05-19 The Procter & Gamble Company Personal care compositions with two benefit phases
JP6453485B2 (ja) 2014-12-19 2019-01-16 ザ プロクター アンド ギャンブル カンパニー アラビノース及びエチレンカーボネートを使用したケラチン繊維の整形
EP3297730A1 (de) 2014-12-19 2018-03-28 The Procter and Gamble Company Verfahren zur formgebung von keratinischen fasern
MX2017008204A (es) 2014-12-19 2017-10-06 Procter & Gamble Conformacion de las fibras de queratina mediante el uso de arabinosa y carbonato de etileno.
EP3310325A1 (de) 2015-06-18 2018-04-25 The Procter and Gamble Company Formung von keratinfasern mit dialdehydverbindungen
JP6615916B2 (ja) 2015-06-18 2019-12-04 ザ プロクター アンド ギャンブル カンパニー ２−オキサゾリジノン化合物を使用したケラチン繊維の整形
CN105267066B (zh) 2015-10-08 2019-06-11 知识产权全资有限公司 用于处理头发的方法及其试剂盒
CN105902404A (zh) 2016-06-14 2016-08-31 知识产权全资有限公司 强发成分以及强发的方法
CN111494227A (zh) 2016-05-19 2020-08-07 知识产权全资有限公司 强发成分以及强发的方法
CN106265109A (zh) 2016-08-22 2017-01-04 知识产权全资有限公司 强发成分以及强发并使头发具有极佳手感的方法
CN111225652A (zh) 2017-10-20 2020-06-02 宝洁公司 气溶胶泡沫洁肤剂
EP3697375B1 (de) 2017-10-20 2021-12-01 The Procter & Gamble Company Aerosolschaum-hautreinigungsmittel
EP3720568B1 (de) 2017-12-08 2022-01-12 The Procter & Gamble Company Screening-verfahren für milde hautreiniger
BE1026073B1 (nl) * 2018-03-05 2019-10-07 Purna Pharmaceuticals Nv Verbeterde werkwijze voor het maken van een farmaceutische emulsie
US10369396B1 (en) 2018-11-09 2019-08-06 Battelle Memorial Institute Assembly for decontaminating and method of manufacturing the assembly
CN113015904A (zh) 2018-11-29 2021-06-22 宝洁公司 用于筛选个人护理产品的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058886A (en) * 1957-08-20 1962-10-16 Dyk & Company Inc Van Skin-protecting sunscreening process
US3836528A (en) * 1968-07-23 1974-09-17 Dainippon Pharmaceutical Co Alpha-(5-nitro-2-furyl)nitrones
CA1138474A (en) * 1978-03-08 1982-12-28 Riekert Kok Process for the preparation of a 1,2-dioxime
US4401649A (en) * 1981-07-20 1983-08-30 Polaroid Corporation Sunscreen method
EP0496434B1 (de) * 1987-10-22 1999-02-03 The Procter & Gamble Company Chelatbildner enthaltende Lichtschutzmittel
US5155110A (en) * 1987-10-27 1992-10-13 Warner-Lambert Company Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition

Also Published As

Publication number Publication date
CA2079485A1 (en) 1991-10-27
ES2199214T3 (es) 2004-02-16
AU7756591A (en) 1991-11-11
EP0611301A1 (de) 1994-08-24
AU662101B2 (en) 1995-08-24
US5364617A (en) 1994-11-15
CA2079485C (en) 1999-05-11
ATE242625T1 (de) 2003-06-15
WO1991016034A1 (en) 1991-10-31
EP0611301B1 (de) 2003-06-11
DE69133277T2 (de) 2004-04-08
EP0611301A4 (de) 1993-03-01

Similar Documents

Publication Publication Date Title
DE69133277D1 (de) Chelat-zubereitungen, die oximverbindungen enthalten
ATE195247T1 (de) Chelat-zubereitung, die alpha-diamin-verbindungen enthalten
NO171684C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktiv polyetylenglykolkarbaminater
NO981269D0 (no) Forbindelser som forsterker virkningen av retinoider
AU547674B2 (en) 1,2,6-thiadiazine-3,5-dione-1,1-dioxides
SE8302693D0 (sv) Heterocyclische verbindungen
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
ATE224T1 (de) 1,2-dihydro-chinolin-2-on-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
SE8204237D0 (sv) Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav
ATE69239T1 (de) Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung.
BR8802021A (pt) Agentes repelentes de insetos e de acaros,processos para o combate a insetos e acaros e para a preparacao de agentes derivados e processo para sua preparacao
FI834790A (fi) Foerfarande foer framstaellning av dietylaminoalkoxibenzhydrol-derivat.
SE8106441L (sv) 2,6-c-dimetyltyrosin?721-d-aminosyra?722-omega-aminokapronsyra-och-gamma-aminosmorsyraderivat av metioninencefalin
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
ES435197A1 (es) Procedimiento para preparar derivados de triazina.
ES2073460T3 (es) Fenilalquilaminas y los fungicidas que las contienen.
DE69106323T2 (de) Imidazol-Derivate, Verfahren zu deren Herstellung und diese enthaltende Zusammenstellungen.
SE7904543L (sv) Nya joniska bensen-polyjodidderivat for anvendning som kontrastmedel vid rontgenbehandling
SE8504346D0 (sv) N-alkyl(en)-n-(o,o-disubstituerad tiofosforyl)-n',n'-disubstituerade glycinamider, sett att framstella dessa samt akaricid, insekticid och fungicid, innehallande dess foreningar som verksam bestandsdel
NO964735L (no) Adenosin-derivater
ES2078651T3 (es) Compuesto de piridinsulfonamida sustituida o una sal del mismo, procedimiento para su preparacion y herbicida que lo contiene.
NO933691L (no) Tiokarbamatsulfoksydsammensetning for avholdenhet fra inntakelse av etanol
ES8106537A1 (es) Procedimiento de preparacion de nuevos fosfatos de n-(fenilosubstituido)-n-(alcoxicarbonilalcohil)-acetamidas
DE3270999D1 (de) N-substituted-tetrahydroisophthalimide derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee